About Iasis Partners, LLC

Iasis Partners, LLC is a drug development consultancy providing tailored support to biopharmaceutical companies navigating the intricacies of drug development from proof-of-concept to market.  

We assist clients in planning and implementing successful drug development programs and in formulating approaches to anticipate, manage, and mitigate risks inherent in the drug development process.  

Iasis Partners provides efficient, customized services based upon each client's individual needs and objectives with a focus on strategic planning and clinical and regulatory support.  The combined expertise of our partners also provides support in preclinical safety and toxicology, pharmacokinetics, statistics, data management, and clinical operations.  We support all stages of product development across all major product classes and therapeutic areas.  

By design, we have remained limited in size to avoid cumbersome bureaucracy and administrative overhead. This enables us to engage in and work on projects with minimum delay.  We maintain relationships with experts and organizations who can be brought in as needed, and keep our clients' costs to the minimum necessary to pursue projects.

Our considered, independent, and balanced approach to drug development provides objectivity and perspective, adds value to our clients’ projects, improves the probability of success, minimizes cost, and accelerates the time to market by identifying and mitigating risks as early as possible in the product life cycle to avoid wasting time and resources.